Liquidia (NASDAQ:LQDA) Stock Price Down 6.3% – Time to Sell?

Liquidia Corporation (NASDAQ:LQDA) was down 6.3% during trading on Monday . The stock traded as low as $70.85 and last traded at $73.25. 1,614,717 shares traded hands during mid-day trading, a decline of 13% from the average session volume of 1,859,574 shares. The stock had previously closed at $78.17.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on the company. Oppenheimer set a $75.00 price target on Liquidia in a research report on Friday, June 5th. BTIG Research boosted their price objective on shares of Liquidia from $59.00 to $109.00 and gave the company a “buy” rating in a research note on Monday, June 22nd. Wall Street Zen lowered shares of Liquidia from a “strong-buy” rating to a “buy” rating in a report on Saturday. Weiss Ratings reissued a “sell (d-)” rating on shares of Liquidia in a report on Tuesday, April 21st. Finally, Needham & Company LLC boosted their price target on shares of Liquidia from $54.00 to $70.00 and gave the company a “buy” rating in a research report on Monday, May 11th. Three investment analysts have rated the stock with a Strong Buy rating, five have given a Buy rating, one has given a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $68.88.

Liquidia Trading Up 0.2%

The company has a debt-to-equity ratio of 1.18, a quick ratio of 2.03 and a current ratio of 2.22. The stock has a market cap of $7.10 billion, a P/E ratio of 570.86 and a beta of 0.58. The stock has a 50-day moving average price of $58.25 and a 200-day moving average price of $44.42.

Liquidia (NASDAQ:LQDA) last announced its earnings results on Monday, May 11th. The company reported $0.52 earnings per share for the quarter, beating analysts’ consensus estimates of $0.41 by $0.11. Liquidia had a net margin of 7.74% and a return on equity of 46.82%. The business had revenue of $132.87 million for the quarter, compared to the consensus estimate of $119.44 million. Liquidia’s quarterly revenue was up 4187.1% compared to the same quarter last year. On average, equities research analysts expect that Liquidia Corporation will post 3.02 EPS for the current year.

Insider Transactions at Liquidia

In other Liquidia news, insider Sarah Krepp sold 24,880 shares of Liquidia stock in a transaction dated Thursday, June 11th. The stock was sold at an average price of $70.28, for a total transaction of $1,748,566.40. Following the completion of the sale, the insider owned 121,863 shares of the company’s stock, valued at $8,564,531.64. The trade was a 16.95% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stephen M. Bloch sold 100,000 shares of Liquidia stock in a transaction dated Monday, June 22nd. The stock was sold at an average price of $75.74, for a total value of $7,574,000.00. Following the sale, the director directly owned 880,073 shares of the company’s stock, valued at approximately $66,656,729.02. This trade represents a 10.20% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 2,302,030 shares of company stock valued at $132,996,894. Insiders own 25.60% of the company’s stock.

Hedge Funds Weigh In On Liquidia

Large investors have recently modified their holdings of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in Liquidia by 4.7% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 37,681 shares of the company’s stock worth $556,000 after buying an additional 1,700 shares in the last quarter. Goldman Sachs Group Inc. lifted its holdings in shares of Liquidia by 10.7% in the 1st quarter. Goldman Sachs Group Inc. now owns 861,231 shares of the company’s stock worth $12,703,000 after acquiring an additional 82,955 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in shares of Liquidia by 15.2% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 121,756 shares of the company’s stock valued at $1,796,000 after purchasing an additional 16,022 shares in the last quarter. Creative Planning boosted its stake in shares of Liquidia by 40.7% in the 2nd quarter. Creative Planning now owns 26,840 shares of the company’s stock valued at $334,000 after purchasing an additional 7,765 shares in the last quarter. Finally, Legal & General Group Plc grew its holdings in shares of Liquidia by 13.4% during the 2nd quarter. Legal & General Group Plc now owns 94,152 shares of the company’s stock valued at $1,174,000 after purchasing an additional 11,111 shares during the last quarter. 64.54% of the stock is owned by hedge funds and other institutional investors.

Liquidia Company Profile

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).